Anavex Life Sciences Corp (AVXL)

[jimmy667]

Wayne State University Multiple Sclerosis Center with grants direct from NIH is a very probable possibility as well. WSUMSC has heavily invested in A2-73 academically and given the positive findings they made regarding A2-73 and MS; deductive logic would assume that they have made applications for NIH Funding for further research with A2-73.

The 'business model' of academia is applying for and receiving grants. Preclinical A2-73 work was done by WSUMSC.

If AVXL partner is Wayne State and National Institutes of Health for MS it will not be a big pop like Biogen and the juicy cash but it means AVXL does not have to share the pie in the case of success.

Is Biogen feeling so strong that they would wrestle with Celgene when Wayne State MS Center shows continued promise in MS for A2-73?

There are six chambers in a revolver, MS is Biogen's cash cow. An A2-73 Bullet chambered for MS could be extremely damaging to Biogen if they misplay this. The Gun is at the temple of Biogen and Celgene is making side bets.

The Real World reality is maybe that Biogen needs to license A2-73 whether they think it works or not.

"As the numbers get larger the negotiations get more complex" Christopher Missling. This was a statement made in context of partnership possibilities

Show me someone that does not believe there are serious negotiations between Anavex and Biogen and I will show you someone that should possibly be tested for cognitive impairment.